Zynex Inc. (ZYXI)
Bid | 2.08 |
Market Cap | 64.69M |
Revenue (ttm) | 192.35M |
Net Income (ttm) | 2.99M |
EPS (ttm) | 0.09 |
PE Ratio (ttm) | 23.78 |
Forward PE | 16.93 |
Analyst | Hold |
Ask | 2.22 |
Volume | 78,381 |
Avg. Volume (20D) | 248,788 |
Open | 2.23 |
Previous Close | 2.19 |
Day's Range | 2.13 - 2.23 |
52-Week Range | 1.93 - 12.34 |
Beta | 1.10 |
About ZYXI
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by fiel...
Analyst Forecast
According to 3 analyst ratings, the average rating for ZYXI stock is "Hold." The 12-month stock price forecast is $10.25, which is an increase of 378.97% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription

20 hours ago · accessnewswire.com
May 19, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ZYXINEW YORK, NY / ACCESS Newswire / April 13, 2025 / If you suffered a loss on your Zynex, Inc. (NASDAQ:ZYXI) investment and want to learn about a potential recovery under the federal securities laws, fo...